GigaCloud Technology Q2 Net Income Declines; Total Revenues Up 11.0%

GigaCloud Technology Inc (GCT) reported that its second quarter net income declined to $6.1 million from $13.6 million, prior year. Earnings per share was $0.15, compared to $0.43.

Total revenues were $124.0 million, an increase of 11.0% from $111.8 million, a year ago. The company said the increase was primarily due to an increase in service revenue from GigaCloud 3P and product revenue from GigaCloud 1P, partially offset by the decrease in product revenue from off-platform ecommerce.

David Lau, CFO of GigaCloud, said, "We are pleased to see topline growth despite a quarter of supply chain challenges. This is attributable to the company's effort to continue attracting more buyers and sellers as demand continues to rise for large parcel sales and deliveries."

The company expects total revenues to be between $122 million and $127 million in the third quarter of 2022.

Shares of GigaCloud Technology are up 8% in pre-market trade on Friday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT